Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2014
02/13/2014US20140045813 Heteroaromatic compounds as btk inhibitors
02/13/2014US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
02/12/2014EP2695882A1 Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device
02/12/2014EP2694619A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same
02/12/2014EP2694484A1 Pyrimidine derivatives for the treatment of viral infections
02/12/2014EP2694482A1 Wnt pathway antagonists
02/12/2014EP2694481A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
02/12/2014EP2694060A1 Substituted 3-(1h-benzo{d}imidazol-2-yl)-1h-indazole-analogs as inhibitors of the pdk1 kinase
02/12/2014CN103582637A Inhibitors of bruton's tyrosine kinase
02/12/2014CN103582636A (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
02/12/2014CN103582632A 取代的苯并咪唑 Substituted benzimidazoles
02/12/2014CN103582629A 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamides as MGLUR5 modulators
02/12/2014CN103582482A Pharmaceutically active disubstituted triazine derivatives
02/12/2014CN103570704A Quinazoline derivative with oxazolidinone ring side chain as well as preparation and application
02/12/2014CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines
02/12/2014CN103570692A Quinazoline derivative with ethylene imine ring side chain as well as preparation and application
02/12/2014CN103570691A Chiral pyrrolidine functionalized imidazolium salt, and preparation method and application thereof
02/12/2014CN103570690A Salt of imidazolidone derivatives
02/12/2014CN103570688A 2,5-diaminomethylpyrazine compounds, drug compositions, preparation method and use thereof
02/12/2014CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines
02/12/2014CN103570629A Benzanthracene derivatives containing pyrimidinyl, pyrazinyl or triazinyl groups and applications thereof
02/12/2014CN103570628A Benzoindenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application
02/12/2014CN103570627A Indenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application
02/12/2014CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof
02/12/2014CN102906086B Quinazoline compounds
02/12/2014CN102816150B Indole with bacteriostatic activity and derivatives thereof-triazole compounds, and preparation method thereof
02/12/2014CN102596937B Compounds and compositions as protein kinase inhibitors
02/12/2014CN102093282B 肟酯光敏引发剂 Oxime ester photoinitiator
02/12/2014CN102015634B Pesticides
02/11/2014US8648094 IAP BIR domain binding compounds
02/11/2014US8648088 Ethynyl nitrogen containing heteroaryl pyrazolidin-3-one derivatives
02/11/2014US8648069 5-substituted indazoles as kinase inhibitors
02/11/2014US8648067 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands
02/11/2014CA2646678C Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
02/11/2014CA2536622C Inhibitors of cellular necrosis
02/11/2014CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity
02/11/2014CA2501506C Modulation of anxiety through blockade of anandamide hydrolysis
02/06/2014WO2014022858A1 Enzyme-activating compounds and compositions
02/06/2014WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
02/06/2014WO2014022382A2 Antibacterial protein kinase inhibitors
02/06/2014WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor
02/06/2014WO2014021591A2 Novel compound, method for preparing same and pharmaceutical composition comprising same
02/06/2014WO2014020012A1 Quinone compounds and their uses for the treatment of cancer
02/06/2014WO2014019344A1 Bridged ring compounds as hepatitis c virus (hcv) inhibitors and pharmaceutical applications thereof
02/06/2014WO2014019338A1 Protein kinase inhibitors
02/06/2014WO2014019179A1 Method for preparing telaprevir and intermediate thereof
02/06/2014WO2014019092A1 Inhibitors of peptidyl arginine deiminase (pad) enzymes and uses thereof
02/06/2014US20140039189 Novel process for the preparation of acylguanidines and acylthioureas
02/06/2014US20140039021 Antiviral compounds
02/06/2014US20140038993 New compounds
02/06/2014US20140038990 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
02/06/2014US20140038987 SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
02/06/2014US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
02/06/2014US20140038975 Imidazole, Pyrazole, and Triazole Derivatives Useful As Antibacterial Agents
02/06/2014US20140038968 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
02/06/2014US20140038964 Imidazole based lxr modulators
02/06/2014US20140038958 Cdk8-cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer
02/06/2014US20140038952 Substituted Amino-Pyrimidine Derivatives
02/06/2014US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines
02/06/2014US20140038945 Piperazine pde4 inhibitors and uses thereof
02/06/2014US20140038943 Serotonin receptor modulator
02/06/2014US20140038938 Substituted dihydropyrazolones and their use
02/06/2014US20140037754 Aminopyrimidines useful as kinase inhibitors
02/05/2014EP2692726A1 Anti-viral compounds
02/05/2014EP2691390A1 Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide
02/05/2014EP2691389A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
02/05/2014EP2691388A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
02/05/2014EP2691384A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
02/05/2014EP2691375A1 Substituted benzimidazoles
02/05/2014EP2691095A2 Imidazolyl amide compounds and uses related thereto
02/05/2014EP2690957A1 Penoxsulam as an herbicide in alfalfa
02/05/2014CN103562203A Process for the preparation of 1-(2-methyl-4-(2, 3, 4, 5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L- proline-N, N- dimethylamide
02/05/2014CN103562202A BCL-2/BCL-XL inhibitors and therapeutic methods using the same
02/05/2014CN103562201A Substituted benzoazepines as TOLL-like receptor modulators
02/05/2014CN103562200A Novel imidazole derivatives useful for the treatment of arthritis
02/05/2014CN103562191A Nitrogen-containing saturated heterocyclic compound
02/05/2014CN103562186A Substituted benzoazepines as toll-like receptor modulators
02/05/2014CN103561772A Immunoconjugates, compositions containing them, and methods of making and use
02/05/2014CN103554089A Diheterocyclic compound as well as synthesis method and application thereof
02/05/2014CN103554042A Triazole compounds that modulate hsp90 activity
02/05/2014CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
02/05/2014CN103551193A N2 substituted 1,2,3-triazole ligand/Cu(I) composite catalyst, as well as synthesis and applications thereof
02/04/2014US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
02/04/2014US8642628 Pyrrole inhibitors of S-nitrosoglutathione reductase
02/04/2014US8642626 Ethinyl-pyrazole derivative
02/04/2014US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
02/04/2014US8642609 Modulators of ATP-binding cassette transporters
02/04/2014US8642585 Indanyloxydihydrobenzofuranylacetic acids
02/04/2014US8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives
02/04/2014US8642025 Hepatitis C virus inhibitors
02/04/2014CA2491191C Receptor-type kinase modulators and methods of use
01/2014
01/30/2014WO2014017643A1 Difluoromethylene compound
01/30/2014WO2014017569A1 Pharmaceutical product for lowering blood ldl
01/30/2014WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof
01/30/2014WO2014017094A1 Organic electroluminescence element
01/30/2014WO2014015931A1 Materials for organic electroluminescent devices
01/30/2014WO2008019124A8 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
01/30/2014US20140031368 Selective hdac inhibitors
01/30/2014US20140031365 Use of a polymorph of flibanserin for treating disease
01/30/2014US20140031361 Inhibitors of protein kinases
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 626